Logo

PERHA PHARMACEUTICALS SAS

EIC Accelerator Winner From 2022

LCTB-21: A DYRK1A protein kinase inhibitor for treatment of cognitive decline in Down Syndrome.

Visit Website
France

Articles

EIC Accelerator Funding Supports PERHA Pharmaceuticals in Advancing Cognitive Disorder Therapies

FranceEIC Accelerator2022
Read Article
Back to All Companies

EIC Accelerator Deadline

00
Days
00
Hours
00
Minutes
00
Seconds

How Can We Help You Succeed?

AI Writer

Budget-friendly AI tools, templates and instructions

Advisory Service

Personalized support for teams with in-house writers

Full Writing

Full Writing of all Proposal Sections by Stephan Segler, PhD